Kiora Pharmaceuticals, Inc.

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals is focused on developing advanced therapies for retinal diseases. They target critical pathways underlying vision-threatening conditions using innovative small molecules to slow, stop, or restore vision loss, particularly for conditions with limited or no effective treatments.

Products & Services

KIO-301:A therapy under development for retinal diseases, detailed in the pipeline section.

KIO-104:Another therapy in the pipeline aimed at addressing retinal conditions.

Clinical Trials:Ongoing clinical trials related to their retinal disease therapies.

Specialties

Retinal disease therapies Innovative small molecules Vision restoration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 10000000 MR: - FA: $10,000,000 FAN: 10000000	D: 2023-02-03 FD: 2023-02-03	1 investors

Equity Financing Latest

2023-02-03

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Brian M. Strem

President & Chief Executive Officer

LinkedIn (Pro only)

E

Eric J. Daniels

Chief Development Officer

M

Melissa Tosca

Chief Financial Officer

S

Stefan Sperl

Executive Vice President of CMC and Operations

D

David Hollander

Director

E

Erin Parsons

Director

View 13 more team members with Pro

Unlock Full Team Directory

Recent News